Literature DB >> 2617644

Snake venoms in science and clinical medicine. 3. Neuropharmacological aspects of the activity of snake venoms.

J B Harris1.   

Abstract

Neuromuscular weakness is a common feature of snake bite. The toxins responsible for weakness either block neuromuscular transmission or they are myotoxic and damage skeletal muscle. In this article the major classes of toxins responsible for causing neuromuscular weakness are described. It is shown how a detailed knowledge of the biochemical and pharmacological properties of the toxins is essential if the clinical problems associated with bites by many species are to be properly understood. It is also shown that such an understanding allows apparent discrepancies between 'laboratory' and 'clinical' findings to be resolved.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2617644     DOI: 10.1016/0035-9203(89)90313-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Is the patient brain-dead?

Authors:  R Agarwal; N Singh; D Gupta
Journal:  Emerg Med J       Date:  2006-01       Impact factor: 2.740

Review 2.  New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in India.

Authors:  David A Warrell; José Maria Gutiérrez; Juan J Calvete; David Williams
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

3.  Judicious use of antisnake venom in the present period of scarcity.

Authors:  Srikant R Gadwalkar; N Sunil Kumar; D P Kushal; G Shyamala; M Z Mohammad; Huggi Vishwanatha
Journal:  Indian J Crit Care Med       Date:  2014-11

4.  The Venom of the Spine-Bellied Sea Snake (Hydrophis curtus): Proteome, Toxin Diversity and Intraspecific Variation.

Authors:  Vanessa Neale; Javier Sotillo; Jamie E Seymour; David Wilson
Journal:  Int J Mol Sci       Date:  2017-12-12       Impact factor: 5.923

5.  Australian Sea Snake Envenoming Causes Myotoxicity and Non-Specific Systemic Symptoms - Australian Snakebite Project (ASP-24).

Authors:  Christopher I Johnston; Theo Tasoulis; Geoffrey K Isbister
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

Review 6.  Neurotoxicity in snakebite--the limits of our knowledge.

Authors:  Udaya K Ranawaka; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

7.  Prediction of presynaptic and postsynaptic neurotoxins by combining various Chou's pseudo components.

Authors:  Haiyan Huo; Tao Li; Shiyuan Wang; Yingli Lv; Yongchun Zuo; Lei Yang
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.